Skip to main content

Table 2  Diagnostic performance of the decision tree classifier in the training and testing groups

From: Prediction of the therapeutic efficacy of epirubicin combined with ifosfamide in patients with lung metastases from soft tissue sarcoma based on contrast-enhanced CT radiomics features

 

Training group

Testing group

AUC

0.917

0.856

Sensitivity (%)

75

55.6

Specificity (%)

95

88.2

Accuracy (%)

88.3

76.9

Positive predictive value (%)

88.2

71.4

Negative predictive value (%)

88.4

78.9

95% CI

0.858 ~ 0.969

0.726 ~ 0.967